Monopar Therapeutics Inc.

NASDAQ:MNPR

Biotechnology

Healthcare
$71.06 +2.45%

+$1.58 today

Market cap
$481.56M
Beta
1.54
P/E (TTM)
-37.6
EPS (TTM)
-$1.76
52W Low $29.18High $105.00

Volume 0.12M

Average 0.17M

Private 5-step workspace

Build a MNPR investment thesis

Turn Monopar Therapeutics Inc. research into a structured decision across business quality, moat, management, intrinsic value, and synthesis.

Log in to save your stock analysis
Your answers are private and saved per stock, so you can come back to the thesis later.